NewsRoom Articles - Page 222 of 601

MondayNov 22, 2021 4:20 pm

420 with CNW — Lessons California Has Learned from Prop 64

In 2016, voters in California approved Proposition 64, which allowed the sale of recreational cannabis to adults aged 21 and older and set up a framework for taxing cannabis cultivation and sales. Five years later, California is home to one of the largest cannabis markets in the country with cannabis companies selling $4.4 billion worth of marijuana in 2020. California is also one of the few states that allows both medical and recreational use, having legalized medical marijuana back in 1996. Some experts say that if the state is able to mitigate the issues facing legal cannabis, California could have…

MondayNov 22, 2021 4:20 am

420 with CNW — Infused Drinks Helping the Cannabis Industry Gain Traction

The cannabis industry has seen an exponential increase in demand as more states have launched legal markets, allowing the sale of medical or recreational cannabis. For the past couple of years, the edible and concentrate segments have reigned supreme as consumers have been looking for consumption methods other than smoking flower. These methods are healthier than smoking and allow for more product variety; in addition, their effects kick in differently. Cannabis-infused beverages are another segment poised to take over the market in the next few years. Relatively new to the market, these are alcoholic and nonalcoholic beverages infused with cannabinoids.…

FridayNov 19, 2021 4:20 pm

420 with CNW — Cannabis to Feature at 2022 Edition of California State Fair

The California State Fair is set to resume next year after a hiatus brought on by the coronavirus pandemic. The fair has various new categories, including one for marijuana, which many believe will be pretty competitive. The state legalized the recreational use of cannabis in 2016, with its cultivators playing a crucial part in the state’s economy by generating more than $3 billion annually in licensed marijuana sales. Competitions to determine the flavor and potency of cannabis strains will not be done through smoking but will instead be done using a high-tech and purely scientific approach. Flowers submitted for competition…

FridayNov 19, 2021 4:20 am

420 with CNW — Study Finds That Legalizing Cannabis Doesn’t Cause Increase in Traffic Injuries

A new study has discovered that the move to legalize cannabis in Canada did not translate into a rise in traffic injuries. The study’s findings were reported in the “Drug and Alcohol Dependence” journal. The objective of the researchers was to investigate claims from prohibitionists who argue that enacting laws to legalize marijuana would make roads less safe. Canada approved laws to legalize marijuana, which took effect in October 2018. For their study, the researchers conducted an analysis on emergency-department data gathered from the Alberta and Ontario provinces between April 2015 to December 2019. The researchers found no evidence supporting…

ThursdayNov 18, 2021 4:20 pm

420 with CNW — Biden’s Pick for Top FDA Job Has Prescribed Cannabis-Based Medicine

President Joseph Biden isn’t a big fan of broad, comprehensive cannabis reform. Even though plenty of Democrats and even some Republicans have thrown their weight behind broad legalization, Biden favors decriminalizing cannabis, legalizing medical cannabis, and giving states the freedom to craft their own marijuana policies. This has been a bone of contention for many lawmakers, especially those from the left, and Senate Majority Leader Chuck Schumer stated that he would advance broad federal legalization with or without the president. A recent move by Biden may be a sign of his preference for medical cannabis. On Friday, Biden announced that…

ThursdayNov 18, 2021 8:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces 2022 DehydraTECH(TM) R&D Programs, Including Investigations into Alzheimer’s Disease and Diabetes

Lexaria’s 2022 R&D programs are set to include research on hormone replacement, dementia, rheumatoid disease, and diabetes, among other conditions The program builds on findings from 2021 studies which supported significant advances in the oral nicotine, heart disease, and antiviral markets The 2022 program will continue to focus on the company’s patented DehydraTECH drug delivery platform Lexaria will also be conducting pharmacokinetic and efficacy modeling studies in animals to evaluate DehydraTECH’s overall efficiency In 2021, Lexaria Bioscience (NASDAQ: LEXX) raised approximately $15 million in funding. The money allowed for active work programs throughout the year while supporting significant advances in…

ThursdayNov 18, 2021 8:00 am

Hero Technologies Inc. (HENC) Subsidiary Looks to Leverage Position in $2B Massachusetts Marijuana Market

HENC subsidiary evaluating, pursuing property acquisitions; beginning process to obtain cultivation, sales licenses Sales have doubled in the past year, according to state’s seed-to-sale tracking system HENC working with top cannabis law firm to spearhead the process With Massachusetts reporting marijuana sales reaching $2 billion since the state approved the adult-use market (https://cnw.fm/9CA5M), savvy cannabis companies operating in the state are looking to leverage opportunity for growth. Earlier this year, Hero Technologies (OTC: HENC), a cannabis company pursuing a vertically integrated model, announced a new subsidiary: MassCannabis LLC. The newly formed company is evaluating and pursuing property acquisitions and beginning the process…

ThursdayNov 18, 2021 4:20 am

420 with CNW – New Cannabis Initiative to Push for Federal Legalization Launched

As more states across the United States legalize cannabis for medical and recreational use, the push to federally legalize the herb grows. Thus far, 18 states and Washington, DC, have legalized the recreational adult use of cannabis. Still, cannabis remains illegal to sell, use or possess under federal law, which has in turn made banks refrain from backing the marijuana industry, for fear that it would cause federal issues. Now major marijuana companies are supporting celebrity-infused campaigns to enlist cannabis users to pressure Congress to legalize the plant countrywide. Earlier last week, the Cannabis in Common initiative was launched to…

WednesdayNov 17, 2021 4:20 pm

420 with CNW — Montana Committee Recommends Reversal of CBD Ban in Cannabis Shops

Earlier this year, the governor of Montana signed House Bill 701 into law, setting the stage for Montana to launch a recreational cannabis market in January 2022. Sponsored by Republican Representative Mike Hopkins, the legislation allowed the sale of adult-use cannabis in counties that had voted in favor of the legalization initiative to adults 21 and older and charged the state Department of Revenue with developing administrative rules and issuing recreational cannabis business licenses. However, two proposed rules by the department drew the ire of industry stakeholders who claimed that the rules were not correct interpretations of the legalization bill.…

WednesdayNov 17, 2021 8:00 am

Marijuana Company of America Inc. (MCOA) Is ‘One to Watch’

The VBF acquisition is expected to be accretive to MCOA’s revenue and EBITDA forecasts for 2022 The company launched new subsidiaries in Brazil and Uruguay to distribute its hempsmart premium product line in Latin America The company recently launched a new social media marketing campaign via Instagram, Twitter, TikTok, etc. The global legal marijuana market was valued at $9.1 billion in 2020 and is forecast to grow at a CAGR of 26.7 percent from 2021 to 2028, putting the market value at roughly $30 billion by 2025 Marijuana Company of America (OTC: MCOA) operates and invests in the cannabis sector directly.…